ESTROGENS AND ATHEROSCLEROTIC VASCULAR-DISEASE - LIPID FACTORS

被引:36
作者
NEWNHAM, HH
机构
来源
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM | 1993年 / 7卷 / 01期
关键词
D O I
10.1016/S0950-351X(05)80271-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease remains the major cause of death for postmenopausal women in Western societies. The majority of epidemiological studies indicate that postmenopausal oestrogen replacement therapy is associated with a 50% reduction in the risk of cardiovascular disease, with much of the reduction being mediated by changes in the plasma concentration of cholesterol within high and low density lipoproteins. In addition to favourably influencing the plasma concentration of lipoproteins, oestrogens also influence the complex metabolism of lipoproteins in the arterial wall, helping to impede the formation of the atherosclerotic plaque. Whilst oestrogens alter endothelial function, vascular reactivity and fibrinolysis, these changes are also seen with reduction of LDL cholesterol and may partly reflect the altered concentration of plasma lipoproteins induced by oestrogens. Oral oestrogens have substantially greater favourable effect on LDL and HDL cholesterol than their transdermal counterparts but also result in greater hypertriglyceridaemia. Most progestogens antagonize the beneficial effects of oestrogens on lipoproteins in a dose-dependent manner; however, cyclical use of low doses of progestogens with an oral oestrogen generally retains a net beneficial effect. Lipoprotein levels fluctuate during cyclical therapy, the most adverse changes being noted at the end of the progestogen phase. Lipoprotein concentrations are constant during continuous combined regimens which have the potential for more prolonged exposure to an adverse progestational effect. Despite adverse effects on the lipoprotein profile, animal studies suggest that progestogens do not substantially reverse the beneficial effects of oestrogens on the development of atherosclerosis. Finally, oestrogen therapy may be useful in the managmeent of postmenopausal women with hyperlipidaemia, and also in the secondary prevention of clinical sequelae in women with established atherosclerosis. © 1993 Baillière Tindall.
引用
收藏
页码:61 / 93
页数:33
相关论文
共 144 条
[71]   POPULATION-BASED LIPOPROTEIN LIPID REFERENCE VALUES FOR PREGNANT-WOMEN COMPARED TO NONPREGNANT WOMEN CLASSIFIED BY SEX-HORMONE USAGE [J].
KNOPP, RH ;
BERGELIN, RO ;
WAHL, PW ;
WALDEN, CE ;
CHAPMAN, M ;
IRVINE, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 143 (06) :626-637
[72]  
KNOPP RH, 1991, CURRENT OPINION LIPI, V2, P240
[73]   EFFECTS OF ESTROGEN DOSE AND SMOKING ON LIPID AND LIPOPROTEIN LEVELS IN POSTMENOPAUSAL WOMEN [J].
KRAUSS, RM ;
PERLMAN, JA ;
RAY, R ;
PETITTI, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (06) :1606-1611
[74]   EFFECTS OF HIGH-DENSITY-LIPOPROTEIN ON ACETYLCHOLINE-INDUCED CORONARY VASOREACTIVITY [J].
KUHN, FE ;
MOHLER, ER ;
SATLER, LF ;
REAGAN, K ;
LU, DY ;
RACKLEY, CE .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (15) :1425-1430
[75]   RELATIONSHIP OF ENDOGENOUS SEX STEROID-HORMONES TO LIPIDS AND APOPROTEINS IN POSTMENOPAUSAL WOMEN [J].
KULLER, LH ;
GUTAI, JP ;
MEILAHN, E ;
MATTHEWS, KA ;
PLANTINGA, P .
ARTERIOSCLEROSIS, 1990, 10 (06) :1058-1066
[76]   EFFECTS OF ESTROGEN AND PROGESTERONE ON PLASMA-LIPOPROTEINS AND EXPERIMENTAL ATHEROSCLEROSIS IN THE BABOON (PAPIO SP) [J].
KUSHWAHA, RS ;
LEWIS, DS ;
CAREY, KD ;
MCGILL, HC .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :23-31
[77]   METABOLIC-REGULATION OF PLASMA APOLIPOPROTEIN-E BY ESTROGEN AND PROGESTERONE IN THE BABOON (PAPIO SP) [J].
KUSHWAHA, RS ;
FOSTER, DM ;
BARRETT, PHR ;
CAREY, KD ;
BERNARD, MG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (01) :93-100
[78]   APPROACHES TO LIPID AND LIPOPROTEIN ANALYSIS [J].
LAKER, MF ;
GAME, FL .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1990, 4 (04) :693-717
[79]   A COMPARISON OF THE EFFECTS OF ETHINYL ESTRADIOL AND ESTRADIOL VALERATE ON SERUM AND LIPOPROTEIN LIPIDS [J].
LINDBERG, UB ;
ENK, L ;
CRONA, N ;
SILFVERSTOLPE, G .
MATURITAS, 1988, 10 (04) :343-352
[80]   EFFECTS OF HORMONAL REPLACEMENT ON LIPIDS AND LIPOPROTEINS IN POSTMENOPAUSAL WOMEN [J].
LOBO, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) :925-930